I Shalit

Author PubWeight™ 34.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett 1990 2.05
2 Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1990 1.65
3 Comparison of polyclonal antiserum versus monoclonal antibodies for the rapid diagnosis of influenza A virus infections by immunofluorescence in clinical specimens. J Clin Microbiol 1985 1.65
4 The diagnostic and therapeutic approach to acute bronchiolitis in hospitalized children in Israel: a nationwide survey. Isr Med Assoc J 2000 1.40
5 A survey of current Israeli practices and approach to partially treated meningitis in children. Isr J Med Sci 1995 1.39
6 Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother 1992 1.25
7 Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005 1.14
8 In vitro antibacterial activities of antibiotics against Pseudomonas aeruginosa in peritoneal dialysis fluid. Antimicrob Agents Chemother 1985 1.12
9 Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1986 1.12
10 Structure-function studies of amphiphilic antibacterial peptides. J Med Chem 1993 1.02
11 Q fever endocarditis in Israel and a worldwide review. Scand J Infect Dis 1997 0.99
12 Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect. Clin Infect Dis 2004 0.97
13 Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2. Int J Pept Protein Res 1994 0.94
14 Enhanced repopulation of murine hematopoietic organs in sublethally irradiated mice after treatment with ciprofloxacin. Blood 1991 0.91
15 Synergistic action of amphotericin B and rifampin against Rhizopus species. Antimicrob Agents Chemother 1987 0.90
16 Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis. Am J Med 1987 0.88
17 Maternal and fetal serum and tissue levels of ceftriaxone following preoperative prophylaxis in emergency cesarean section. Chemotherapy 1993 0.87
18 Risk factors for sternal wound infection in children undergoing cardiac surgery: a case-control study. J Hosp Infect 2008 0.85
19 Single-dose pharmacokinetics of imipenem-cilastatin in pediatric patients. Pediatr Pharmacol (New York) 1986 0.85
20 Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis. Am J Med 1987 0.84
21 Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells. Br J Cancer 2006 0.83
22 The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. J Antimicrob Chemother 1992 0.82
23 Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives. Lymphokine Res 1989 0.81
24 Oral ofloxacin therapy for invasive external otitis. Ann Otol Rhinol Laryngol 1991 0.80
25 Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study. J Hosp Infect 2004 0.80
26 Lymphoma in a patient with severe combined immunodeficiency with adenosine deaminase deficiency, following unsustained engraftment of histoincompatible T cell-depleted bone marrow. J Pediatr 1986 0.80
27 Disinfection with 10% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit. Acta Paediatr 2004 0.78
28 Retinol transport proteins and concentrations in human amniotic fluid, placenta, and fetal and maternal sera. Br J Nutr 1985 0.78
29 Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children. Eur J Clin Microbiol Infect Dis 2009 0.77
30 Chloramphenicol in the 1980s. Drugs 1984 0.77
31 Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management. Transpl Infect Dis 2012 0.77
32 Parenteral-oral switch in the management of paediatric pneumonia. Drugs 1994 0.77
33 Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in Israel. Clin Microbiol Infect 2012 0.76
34 Effect of ciprofloxacin on hematologic parameters in breast cancer patients receiving chemotherapy. Eur J Haematol 1995 0.75
35 Decreased antihaemophilic globulin and leucocyte response to epinephrine in preterm infants. Arch Dis Child 1976 0.75
36 Age distribution of anginose mononucleosis. Arch Dis Child 1987 0.75
37 [Intervertebral disc infection in children]. Harefuah 1980 0.75
38 Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity. Isr J Med Sci 1996 0.75
39 [Pediatric research in an office-setting network--a new dimension in pediatric research in Israel]. Harefuah 1999 0.75
40 [Malaria: revised recommendations for prophylaxis]. Harefuah 1988 0.75
41 [Scabies--prevention and treatment]. Harefuah 1986 0.75
42 Granulation tissue concentrations of ofloxacin after oral administration in invasive external otitis. Eur Arch Otorhinolaryngol 1993 0.75
43 [Infections caused by Haemophilus--an update]. Harefuah 1986 0.75
44 Problem of nonclassical measles in the immunization era and the terminology of the various forms of measles. Pediatr Infect Dis 1986 0.75
45 [Anorexia nervosa in a male]. Harefuah 1980 0.75
46 [Medical guidelines for the traveller]. Harefuah 1988 0.75
47 Mononucleosis therapy. Infection 1987 0.75